Screening methods for cytokine inhibitors
作者： Vivian Mak
DOI:
关键词:
摘要: The present invention provides a number of screening methods for evaluatiing compounds capable suppressing cytokine production either in vitro or vivo. generally involve stimulating the cell, exposing portion cells to putative modulating agent and determining subsequent levels cells. Additionally, certain identified by this method.
google.com.ar参考文章(157)
Gholam A. Peyman, Method of treatment of migraine ,(1998)
Diezel Wolfgang, Anhalt Grant, Suppression of eczematous dermatitis by calcium transport inhibition ,(1989)
Ichiro Tsuchida, Takanori Saito, Hideaki Okabe, Transdermal therapeutic formulation ,(1992)
Eric J. Roos, Samir D. Roy, Kuldeepak Sharma, Transdermal administration of buprenorphine ,(1991)
M Kamoun, T M Williams, H W Kim, H Makni, D M Moolten, J A Kant, CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive. Journal of Immunology. ,vol. 148, pp. 2609- 2616 ,(1992)
Ludwig P. Cooymans, Lourens Wals, α,α-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, N-oxides and method of treating diarrhea ,(1986)
Elias W. Packman, Hemorrhoidal, other compositions and methods of treatment ,(1988)
Anat Eitan, Rachel Nachman, Sasson Cohen, Compositions for topical treatment of psoriasis and atopic dermatitis ,(1992)
Raymond Antoine Stokbroekx, Carlos Jan Ernest J Niemegeers, Paul Adriaan Jan Janssen, Jan Vandenberk, 2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides ,(1972)
Barnett S. Pitzele, Michael F. Rafferty, Michael S. Dappen, Opioid agonist compounds ,(1994)